Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjogren's syndrome keratoconjunctivitis sicca

Current Eye Research

Volumn 19, Issue 3, 1999, Pages 201-211

  Pflugfelder, Stephen C ^a,b   Jones, David ^a   Ji, Zhonghua ^a   Afonso, Adolfo ^a   Monroy, Dagoberto ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Conjunctiva; Dry eye; Epidermal growth factor; Inflammatory cytokines keratoconjunctivitis sicca; Sjogren's syndrome

Indexed keywords

CYTOKINE; EPIDERMAL GROWTH FACTOR; FLUORESCEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; RNA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CELL DENSITY; CELL LYSATE; CLINICAL ARTICLE; CONJUNCTIVA; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GOBLET CELL; HOUSEKEEPING GENE; HUMAN; IMPRESSION CYTOLOGY; KERATOCONJUNCTIVITIS SICCA; LACRIMAL FLUID; MALE; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SJOEGREN SYNDROME; STAINING;

ADULT; AGED; CELL COUNT; CONJUNCTIVA; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; FEMALE; HUMANS; INTERLEUKINS; KERATOCONJUNCTIVITIS SICCA; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SJOGREN'S SYNDROME; TEARS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032709209     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.19.3.201.5309     Document Type: Article

References (52)

1. Sjogren H, Block KJ. Keratoconjunctivitis sicca and the Sjögren's syndrome. Surv Ophthalmol. 1971;16:145-59.
2. Pflugfelder SC, Tseng SCG, Sanabria O, Kell H, Garcia CG, Felix C, Feuer W, Reis BL. Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation. Cornea. 1998;17:38-56.
3. Pflugfelder SC, Tseng SCG, Yoshino K, Monroy D, Felix C, Reis B. Correlation of goblet cell density and mucosal epithelial membrane mucin expression with rose bengal staining in patients with ocular irritation. Ophthalmology. 1997;104:223-35.
4. Pflugfelder SC, Huang AJW, Feuer W, Chuchovski PT, Pereira I, Tseng SCG. Conjunctival cytologie features of primary Sjögren's syndrome. Ophthalmology. 1990;97: 985-991.
5. Tseng SCG. Staging of conjunctival squamous metaplasia by impression cytology. Ophthalmology. 1985;92:728-33.
6. Danjo Y. Ocular surface damage and tear lactoferrin in dry eye syndrome. Acta Ophthalmol 1994;72:433-7.
7. Gilbard JP, Farris RL, Santamaria IJ. Osmolarity of tear microvolumes in keratoconjunctivitis sicca. Arch Ophthalmol. 1978;96:677-81.
8. Goren MB, Goren SB. Diagnostic tests in patients with symptoms of keratoconjunctivitis sicca. Am J Ophthalmol. 1988;106:570-4.
9. Janssen PT, van Bijsterveld OP. Tear fluid proteins in Sjögren's syndrome. Scand J Rheumatol Suppl. 1986;61:224-7.
10. Mackie IA, Seal DV. Diagnostic implications of tear protein profiles. Br J Ophthalmol 1984;68:321-4.
11. McCollum CJ, Foulks GN, Bodner B, Shepard J, Daniels K, Cross V, Kelly L, Cavanagh HD. Rapid assay of lactoferrin in keratoconjunctivitis sicca. Cornea. 1994; 13:505-8.
12. Van Setten GB. Epidermal growth factor in human tear fluid: increased release but decreased concentration during reflex tearing. Current Eye Res. 1990;9:79-83.
13. Yoshino K, Monroy D, Pflugfelder SC. Cholinergic stimulation of lactoferrin and epidermal growth factor secretion by the human lacrimal gland. Cornea. 1996;15:617-621.
14. Carraway KLI, Cantley LC. A neu acquaintance of ErbB3 and ErbB4: a role for receptor heterodimenzation in growth signaling. Cell. 1994;78:5-8.
15. Carraway KL, Carothers Carraway CA, Carraway KLI. Roles of ErbB-3 and ErbB-4 in the physiology and pathology of the mammary gland. J Mammary Gland Biol Neoplasia. 1997;2:187-97.
16. Nava A, Barton K, Monroy D, Pflugfelder SC. The effects of age, gender, and fluid dynamics on the concentration of tear film epidermal growth factor. Cornea. 1997;16:430-438.
17. Van Setten, GB, Viinikka L, Tervo T. Epidermal growth factor is a constant component of normal human tear fluid. Graefe's Arch Clin Exp Ophthalmol. 1989;22:184-187.
18. Van Setten GB. Ocular disease leads to decreased concentrations of epidermal growth factor in the tear fluid. Curr Eye Res. 1991;10:523-7.
19. Hikichi T, Yoshida A, Tsubota K. Lymphocytic infiltration of the conjunctiva and the salivary gland in Sjögren's syndrome. Arch Ophthalmol. 1993;111:21-2.
20. Raphael M, Bellefgih S, Piette J Ch, Le Hoang Ph, Debre P, Chomette G. Conjunctival biopsy in Sjögren's syndrome: correlations between histologic and immunohistochemical features. Histopathology. 1988;13:191-202.
21. Jones DT, Monroy D, Ji Z, Atherton SS, Pflugfelder SC. Sjögren's syndrome: cytokine and Epstein-Barr virus gene expression within the conjunctival epithelium. Invest Ophthalmol Vis Sci. 1994;35:3493-3504.
22. Baudouin C, Brignole F, Becquet F, Pisella PJ, Goguel A. Flow cytometry in impression cytology specimens. A new method for evaluation of conjunctival inflammation. Invest Ophthalmol Vis Sci. 1997;38:1458-64.
23. Zsubota K. Conjunctival epithelium expression of HLA-DR in dry eye patients. Ophthalmologica. 1999;213:16-9.
24. Yannopoulos DI, Roncin S, Lamour A, Pennec YL, Moutsopoulos HM, Youinou P. Conjunctival epithelial cells from patients with Sjögren's syndrome inappropriately express major histocompatability molecules. J Clin Immunol. 1992;51:259-65.
25. Markusse HM, Huysen JC, Nieuwenhuys EJ, Swaak AJ. Beta 2 microglobulin in tear fluid from patients with primary Sjögren's syndrome. Ann Rheum Dis. 1992;51: 503-5.
26. Tishler M, Yaron I, Geyer D, Shirazi I, Naftalier E, Yaron M. Elevated tear interleukin-6 levels in patients with Sjögren's syndrome. Ophthalmology. 1998;105:2327-9.
27. Gunduz K, Ozdemir O. Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjögren's syndrome. Acta Ophthalmol. 1994;72:442
28. Tabbara KF, Frayha RA. Alternate-day steroid therapy for patients with primary Sjögren's syndrome. Ann Ophthalmol. 1983;15:358-61.
29. Marsh P, Pflugfelder SC. Topical non-preserved methylprednisolone therapy of keratoconjunctivitis sicca in Sjogren's syndrome. Ophthalmology. 1999; in press.
30. Gillitzer R, Ritter U, Spandau U, Goebeler M, Brocker EB. Differential expression of GRO-alpha and IL-8 mRNA in psoriasis: a model for neutrophil migration and accumulation in vivo. J Invest Dermatol. 1996;107:778-82.
31. Yoshinaga Y, Higaki M, Terajima S, Ohkubo E, Nogita,T. Miyasaka,N.; Kawashima,M.et al. Detection of inflammatory cytokines in psoriatic skin. Arch Dermatol Res. 1995;287:158-64.
32. Bruch-Gerharz D, Fehsel K, Suschek C, Michel G, Ruzicka T, Kolb-Bachofen V. A proinflammatory activity of interleukin 8 in human skin: expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes. J Exp Med. 1996;184:2007-12.
33. Grossman RM, Kupper T, Yourish D, Piperno AG, Murphy DP, May LT, Sehgel PB, Gottlieb AB. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA. 1989;86:6367-71.
34. Cooper KD. Psoriasis. Leukocytes and cytokines. Dermatol Clin. 1990;8:737-41.
35. McKenzie RC, Saunder DN. Keratinocyte cytokines and growth factors. Functions in skin immunity and homeostasis. Dermatol Clin. 1990;8:649-60.
36. de Jong EM, Ferner CM, de Zwart A, Wauben-Penris PJ, Korstanje C, van de Kerkhof PC. Effects of topical treatment with budesonide on parameters for epidermal proliferation, keratinization and inflammation in psoriasis. J Dermatol Sci. 1995;9:185-94.
37. Smith KJ, Skelton HG. Effects of cyclosporine on cytokines and cytokine receptors in psoriasis [letter; comment]. J Am Acad Dermatol. 1997;36:656-8.
38. Michel G, Auer H, Kemeny L, Booking A, Ruzicka T. Antioncogene P53 and mitogenic cytokine interleukin-8 aberrantly expressed in psoriatic skin are inversely regulated by the antipsoriatic drug tacrolimus (FK506). Biochem Pharmacol. 1996;51:1315-20.
39. Lemster BH, Carroll PB, Rilo HR, Johnson N, Nikaein A, Thomson AW. IL-8/IL-8 receptor expression in psoriasis and the response to systemic tacrolimus (FK506) therapy. Clin Exp Immunol, 1995;99:148-54.
40. Fox RI, Robinson CA, Curd JG, Kozir F, Howell FV. Sjögren's syndrome: proposed criteria for classification. Arthritis Rheum. 1986;29:577-85.
41. Pflugfelder SC, Tseng SCG, Pepose J, Fletcher MA, Klimas N, Feuer W. Epstein-Barr virus infection and immunologic dysfunction in patients with aqueous tear deficiency. Ophthalmology. 1990;97:313-23.
42. Jones DT, Monroy D, Pflugfelder SC. A novel method of tear collection. Comparison of glass capillary tubes with porous polyester rods. Cornea. 1997;16:450-458.
43. Wilson SE, He YG, Lloyd SA. EGF, EGF receptor, basic FGF, TGF-beta-1, and IL-1 alpha mRNA in human corneal epithelial cells and stromal fibroblasts. Invest Ophthalmol Vis Sci. 1992;33: 1756-1765.
44. Lausch RN, Chen SH, Tumpey TM, Su YH, Oakes JE. Early cytokine synthesis in the excised mouse cornea. J Interferon Cytokine Res. 1996;16:35-40.
45. Sakamoto S, Inada K, Chiba K, Yoshida M, Tazawa Y. Production of IL-6 and IL-1 alpha by human corneal epithelial cells. Nippon Ganka Gakkai Zasshi. 1991;95:728-32.
46. Souaze F, Ntodou-Thome A, Tran CY, Rostene W, Forgez P. Quantitative RT-PCR: limits and accuracy. BioTechniques. 1996;21:280-5.
47. Sporn MB, Roberts AB. The Multifunctional Nature of Peptide Growth Factors. In: Sporn MB, Roberts AB, eds. Peptide Growth Factors and Their Receptors I. New York: Springer-Verlag, 1990:3-15.
48. Chrousos GP. The hypothalmic-pituitary adrenal axis and immune mediated inflammation. N Engl J Med. 1995;332:1351-61.
49. Warbrick EV, Thomas AL, Williams CM. The effects of cyclosporin A, dexamethasone and other immuno-modulatory drugs on induced expression of IL-3, IL-4 and IL-8 mRNA in a human mast cell line. Toxicology. 1997;116:211-8.
50. Gupta A, Monroy D, Ji Z, Yoshino K, Huang A, Pflugfelder SC. Transforming growth factor beta-1 and beta-2 in human tear fluid. Cur Eye Res. 1986;15: 605-614.
51. Massaque J. The transforming growth factor-beta family. Annu Rev Cell Biol. 1990;68:597-641.
52. Sporn MB, Roberts AB. Transforming growth factor-beta. Multiple actions and potential clinical applications. JAMA. 1989;262:938-41.